IGF2 and colorectal cancer: These results were corroborated by investigating the correlation between IGF2 and miRNA‐483‐3p expression across a panel of 242 colorectal cancer patients from The Cancer Genome Atlas [TCGA; Fig. 1E, Pearson Correlation Coefficient (PCC = 0.87, P < 0.0001)], and a panel of 39 colorectal cancer cell lines from the Cancer Cell Line Encyclopedia (CCLE, Fig. 1F and Table S5; PCC = 0.91; P = 1.46e‐15).